Pay in 4 interest-free payments of $112.50 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
54 / Diabetes Type 2 / Linagliptin-d4 / 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3
48 / High Blood Pressure (Hypertension) / Azilsartan-d4 / 1-[[2’-(2
/ β-D-Lac-Ethyl-Amine / β-Lac-Et-NH2
C21H36N2O14 / 540
C28H38D6O2 / 418
MV100050: Tris-GalNAc-PEG5-COOH label-new 54 / Diabetes Type 2C75H134N10O35 1735. 9 A triantennary N acetylgalactosamine (Tri GalNAc) ligand presenting three GalNAc residues on a tris based branched scaffold, equipped with a terminal carboxylic acid through a discrete, monodisperse pentaethylene glycol (PEG5) spacer. The carboxylic acid can be activated to NHS, sulfo NHS, or pentafluorophenyl (PFP) esters and reacted with amine functionalized payloads, antibodies, peptides, or lysine residues on proteins to form
US$ 16.99
US$ 16.99
US$ 182.00
US$ 85.00
US$ 14.99
US$ 16.99
